Sands Capital Ventures Discovery Fund III L.P. 13D and 13G filings for Acumen Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-07-12 9:08 pm Purchase |
2021-07-06 | 13G | Acumen Pharmaceuticals, Inc. ABOS |
Sands Capital Ventures Discovery Fund III L.P. | 3,417,075 8.840% |
3,417,075 (New Position) |
Filing |